Intercepting Premalignant, Preinvasive Breast Lesions Through Vaccination

Breast cancer (BC) prevention remains the ultimate cost-effective method to reduce the global burden of invasive breast cancer (IBC). To date, surgery and chemoprevention remain the main risk-reducing modalities for those with hereditary cancer syndromes, as well as high-risk non-hereditary breast l...

Descripción completa

Detalles Bibliográficos
Autores principales: Zachariah, Nadia Nocera, Basu, Amrita, Gautam, Namrata, Ramamoorthi, Ganesan, Kodumudi, Krithika N., Kumar, Nagi B., Loftus, Loretta, Czerniecki, Brian J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652247/
https://www.ncbi.nlm.nih.gov/pubmed/34899753
http://dx.doi.org/10.3389/fimmu.2021.786286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652247/
https://www.ncbi.nlm.nih.gov/pubmed/34899753
http://dx.doi.org/10.3389/fimmu.2021.786286

Ejemplares similares